Enterococcus gallinarum

Enterococcus gallinarum is a Gram-positive bacterium that belongs to the genus Enterococcus. It is a facultative anaerobic organism, meaning it can grow in both the presence and absence of oxygen. E. gallinarum is notable for its intrinsic resistance to vancomycin, an antibiotic that is often used as a last resort for treating serious infections caused by Gram-positive bacteria.

Morphology and Identification

Enterococcus gallinarum is a cocci-shaped bacterium that typically forms in pairs or short chains. It is non-motile and does not form spores. The cells are approximately 0.6 to 2.0 micrometers in diameter. E. gallinarum can be distinguished from other enterococci by its ability to produce a yellow pigment and its motility, which is rare among enterococci.

Genomic Characteristics

The genome of Enterococcus gallinarum is composed of a single circular chromosome. It has been sequenced and analyzed to understand its resistance mechanisms and pathogenic potential. The presence of the vanC gene cluster is responsible for its intrinsic resistance to vancomycin, differentiating it from other vancomycin-resistant enterococci (VRE) that acquire resistance through horizontal gene transfer.

Pathogenicity

Enterococcus gallinarum is considered an opportunistic pathogen. It is part of the normal intestinal flora in humans and animals but can cause infections in immunocompromised individuals. Infections caused by E. gallinarum include bacteremia, endocarditis, and urinary tract infections. The intrinsic resistance to vancomycin poses a challenge in treating infections caused by this organism.

Clinical Significance

The clinical significance of Enterococcus gallinarum lies in its ability to cause nosocomial infections, particularly in hospital settings where patients may have weakened immune systems. The intrinsic vancomycin resistance necessitates alternative treatment strategies, often involving the use of antibiotics such as linezolid or daptomycin.

Epidemiology

Enterococcus gallinarum is found worldwide and is commonly isolated from the gastrointestinal tracts of humans and animals. It is also found in the environment, including soil and water. The spread of E. gallinarum in healthcare settings is of particular concern due to its resistance profile.

Treatment and Management

Management of infections caused by Enterococcus gallinarum involves the use of antibiotics to which the organism is susceptible. Due to its intrinsic resistance to vancomycin, treatment options may include linezolid, daptomycin, or other agents based on susceptibility testing. Infection control measures in healthcare settings are crucial to prevent the spread of this organism.

Prevention

Preventive measures include strict adherence to infection control protocols in healthcare settings, such as hand hygiene, use of personal protective equipment, and environmental cleaning. Monitoring and surveillance of antibiotic resistance patterns are also important to prevent the spread of resistant strains.

Research Directions

Ongoing research on Enterococcus gallinarum focuses on understanding its resistance mechanisms, pathogenicity, and potential targets for new antimicrobial agents. Studies are also exploring the role of the gut microbiome in the colonization and infection dynamics of E. gallinarum.

See Also

• Enterococcus faecalis
• Enterococcus faecium
• Vancomycin-resistant enterococcus